The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease by J Antonio Marin-Neto, Anis Rassi Jr, Alvaro Avezum Jr, Antonio C Mattos, Anis Rassi

Get full text

Five-year cardiovascular outcomes in patients with chronic myeloid leukemia treated with imatinib, dasatinib, or nilotinib: A cohort study using data from a large multinational col... by Rafael Amorim Belo Nunes, Precil Diego Miranda de Menezes Neves, Leandro Menezes Alves da Costa, Philip Bachour, Marcelo José de Carvalho Cantarelli, Gustavo Bernardes de Figueiredo Oliveira, Álvaro Avezum Jr.

Get full text

INTERBLEED: Design of an International Study of Risk Factors for Gastrointestinal Bleeding and Cardiovascular Events After Gastrointestinal Bleeding by Jacqueline Bosch, PhD, Paul Moayyedi, MD, PhD, Marco Alings, MD, PhD, Alvaro Avezum, Jr., MD, PhD, Shrikant I. Bangdiwala, PhD, Alan Barkun, MD, CM, MSc, Federico Cassella, MD, Aloisio Marchi da Rocha, MD, PhD, Irfan Duzen, MD, Robert Enns, MD, Nauzer Forbes, MD, MSc, Leah Hamilton, MSc, Shofiqul Islam, PhD, Mustafa Kilickap, MD, MSc, Paul Kruger, MBBS, Yan Liang, MD, Jose C. Nicolau, MD, Rafael Nunes, MD, PhD, Martin O’Donnell, MD, PhD, Gustavo Oliveira, MD, PhD, Alejandro Rey, MD, Yihong Sun, MD, Thomas Vanassche, MD, Peter Verhamme, MD, Michael Walsh, MD, PhD, Zhenyu Wang, MD, Cynthia Wu, MD, Li Zhao, MD, Jun Zhu, MD, John W. Eikelboom, MBBS

Get full text